Intellego

Skip to Main Content »

Search Site

You're currently on:

The NDA Process: Requirements for Obtaining Approval for a New Drug in the USA

Double click on above image to view full picture

Zoom Out
Zoom In

More Views

The NDA Process: Requirements for Obtaining Approval for a New Drug in the USA

Be the first to review this product

£ 100.00
Add Items to Cart

Quick Overview

A New Drug Application (NDA) is a regulatory vehicle through which Sponsors formally propose that the FDA approve a new drug for sale and marketing in the USA.

Product Description

A New Drug Application (NDA) is a regulatory vehicle through which Sponsors formally propose that the FDA approve a new drug for sale and marketing in the USA.

For successful FDA approval, what content and format requirements are necessary to comply with FDA guidelines? How do you plan your submission timetable?

This module provides regulatory professionals with the requirements to complete and submit NDAs for FDA approval.


Who will benefit from this module?
This module is primarily aimed at regulatory professionals who are new to the New Drug Application (NDA) process. It will also benefit professionals in clinical research, data processing, project management and marketing, and whose role involves interaction with the Food and Drug Administration (FDA).